Chicago Saturday, Dec 16, 2017 6:49 pm • London Saturday, Dec 16, 2017 6:49 pm • Zurich Saturday, Dec 16, 2017 6:49 pm

HomeWho Am IContact

No Comments

Published Entries

Who reported the first use of bromocriptine in humans for the treatment of hyperprolactinemia?

Published online 31 May, 2014 in Pituitary, Editor Mark E. Molitch (Springer Science & Business Media, New York) Title “We stand Upon the Shoulders of Giants” (see page 12)

PM LutterbeckPeter Lutterbeck, later a neurologist, was the first to give bromocriptine to humans with hyperprolactinemia. He wrote about this in an interesting commentary. “As a your physician … at Sandoz Pharmaceutical Company, he learned of newly developed ergot alkaloids with anti-fertility properties … One such compound, CB-154 (later named bromocriptine), was found to have an anti-prolactin effects in animals … He proposed studying its clinical effect in certain prolactin- and dopamine-related conditions, particularly galactorrhea and Parkinson’s disease. His superiors rejected the idea as a long shot, irrelevant to the goal of creating new anti-fertility drugs, and transferred him to another division of the company. He kept hold of the idea till an encounter with a gynecologist treating patients with galactorrhea gave him an adequate patient group for a small-scale clinical trial. First, drug safety was tested semi-secretly on one person: the author himself. As there was no ill effect, he obtained informed consent from three patients with severe galactorrhea and gave them CB-154, with good results in all three. “Dr. Besser, del Pozo and Flückiger were mentioned above. Dr. Alan McNeilly is a reproductive endocrinologist who has done work on the effects of prolactin on the ovary.

Lutterbeck PM, Pryor JS, Varga I, Venner R. Treatment of non-puerperal galactorrhea with ergot alkaloid. BMJ 1971;3:228. Varga I, Lutterbeck PM, Pryor JS, Venner R, Erb H. Suppression of puerperal lactation with an ergot alkaloid: a double-blind study, BMJ 1972;2:745

p.s. Dr. Lutterbeck was considered one of the unsung heroes in Neuroendocrinology of the last Century.

Comments Off on Who reported the first use of bromocriptine in humans for the treatment of hyperprolactinemia?